Practice

Health Law

Every player in the global health industry has to deal with an exceedingly complex regulatory landscape. What’s more, this landscape is constantly changing. Consider the sea change in regulation brought about by the Affordable Care Act, and the ongoing repercussions and developments.

Hogan Lovells Publications

340B program: CMP Final Rule effective and implementation date accelerated to January 1, 2019

Yesterday, the Health Resources and Services Administration (HRSA) issued a Final Rule (Final Rule) that accelerates the effective and implementation date of the 340B Ceiling Price and...

Quick view Full view

Hogan Lovells Publications

Regulatory Insights for Life Sciences and Health Care Investments: Drug Pricing and Reimbursement

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure could cost you millions of dollars.

Quick view Full view

Hogan Lovells Publications

FDA wants to hear from you: Proposed framework for regulating output of digital health tools accompanying prescription drugs as labeling Pharmaceutical and Biotechnology Alert

On 20 November the Food and Drug Administration (FDA) published a request for comments on a proposed framework for regulating the output of digital health applications disseminated by or on ...

Quick view Full view

Hogan Lovells Publications

Indonesia to relax foreign investment rules Finance Alert

As part of its 16th economic package, the Government of Indonesia (GOI) announced on 16 November 2018 that in order to attract further foreign investment, it intends to relax the...

Quick view Full view

Hogan Lovells Publications

Medicare further expands payment for and coverage of telehealth and similar services Health Alert

Through several recently published rules, the Centers for Medicare & Medicaid Services (CMS) is making it possible for Medicare beneficiaries to have greater access to health care...

Quick view Full view
Loading data